As acquired resistance of targeting ALK in the advanced stage setting emerges inevitably, TKIs are able to inhibit cancer cell proliferation, hinder tumor growth, and control cancer metastasis, but not to eradicate or cure the disease. Here, ALK is linked to cancer.